BETA
BETA
Titan Pharmaceuticals
TTNP64
$5.54arrow_drop_down5.07%-$0.29
Penny Stock
TTNP64
$5.54
arrow_drop_down5.07%Performance History
| Key Stats | |
|---|---|
| Open | $5.71 |
| Prev. Close | $5.84 |
| EPS | -6.42 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $5.38M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 5.54 | 5.71 |
| 52 Week Range | 4.24 | 14.00 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -6.42 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Titan Pharmaceuticals (TTNP)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. David Elliot Lazar
- Headquarters
- South San Francisco
- Employees
- 4
- Exchange
- NASDAQ
Keep an eye on Titan Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the market capitalization of Titan Pharmaceuticals (TTNP)?
Titan Pharmaceuticals (TTNP) has a market capitalization of $5.22M. The average daily trading volume is 8.91K, indicating the stock's liquidity and investor engagement.
help
What is Titan Pharmaceuticals 's (TTNP) price per share?
The current price per share for Titan Pharmaceuticals (TTNP) is $5.54. The stock has seen a price change of -$0.3 recently, indicating a -5.07% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Titan Pharmaceuticals (TTNP)?
For Titan Pharmaceuticals (TTNP), the 52-week high is $14, which is 152.53% from the current price. The 52-week low is $4.24, the current price is 30.75% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Titan Pharmaceuticals (TTNP) a growth stock?
Titan Pharmaceuticals (TTNP) has shown an average price growth of 0.41% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Titan Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Titan Pharmaceuticals (TTNP) stock price performance year to date (YTD)?
As of the latest data, Titan Pharmaceuticals (TTNP) has a year-to-date price change of -32.8%. Over the past month, the stock has experienced a price change of -15.04%. Over the last three months, the change has been -21.81%. Over the past six months, the figure is 2.28%. Looking at a longer horizon, the five-year price change stands at -99.2%.
help
Is Titan Pharmaceuticals (TTNP) a profitable company?
Titan Pharmaceuticals (TTNP) has a net income of -$5.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 39.13% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.72K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $72K. Operating income is noted at -$7.28M. Furthermore, the EBITDA is -$6.57M.
News
NEWS
PENNY STOCKS
SMALL CAP
INTRADAY UPDATE
MARKETS
MOVERS
TRADING IDEAS
4/8/2024Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
MANAGEMENT STATEMENTS
1/25/2024Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
NEWS
EARNINGS
PENNY STOCKS
EUROZONE
COMMODITIES
SMALL CAP
GLOBAL
INTRADAY UPDATE
MARKETS
TRADING IDEAS
12/29/2023Gold Moves Lower; Microbot Medical Shares Slide
NEWS
PENNY STOCKS
SMALL CAP
PRE-MARKET OUTLOOK
MARKETS
MOVERS
TRADING IDEAS
12/29/2023Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
NEWS
EARNINGS
PENNY STOCKS
EUROZONE
COMMODITIES
SMALL CAP
GLOBAL
INTRADAY UPDATE
MARKETS
TRADING IDEAS
12/29/2023Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet
NEWS
PENNY STOCKS
SMALL CAP
PRE-MARKET OUTLOOK
MARKETS
MOVERS
TRADING IDEAS
12/29/2023Why Titan Pharmaceuticals Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.